Ad is loading...
DBMAX
Price
$26.45
Change
-$0.67 (-2.47%)
Updated
Nov 15 closing price
RPMGX
Price
$109.51
Change
-$2.16 (-1.93%)
Updated
Nov 15 closing price
Ad is loading...

DBMAX vs RPMGX

Header iconDBMAX vs RPMGX Comparison
Open Charts DBMAX vs RPMGXBanner chart's image
BNY Mellon Sm/Md Cp Gr A
Price$26.45
Change-$0.67 (-2.47%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.51
Change-$2.16 (-1.93%)
VolumeN/A
CapitalizationN/A
DBMAX vs RPMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBMAX vs. RPMGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMAX is a Buy and RPMGX is a StrongSell.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31B vs. DBMAX (1.27B). RPMGX pays higher dividends than DBMAX: RPMGX (0.05) vs DBMAX (0.00). DBMAX was incepted earlier than RPMGX: DBMAX (16 years) vs RPMGX (32 years). DBMAX is a more actively managed with annual turnover of: 36.02 vs. RPMGX (21.70). DBMAX has a lower initial minimum investment than RPMGX: DBMAX (1000) vs RPMGX (2500). DBMAX annual gain was more profitable for investors over the last year : 22.68 vs. RPMGX (14.13). DBMAX return over 5 years is better than : 16.21 vs. RPMGX (13.50).
DBMAXRPMGXDBMAX / RPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years32 years-
Gain YTD6.5679.46669%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B31B4%
Annual Yield % from dividends0.000.05-
Returns for 1 year22.6814.13161%
Returns for 3 years-32.63-18.72174%
Returns for 5 years16.2113.50120%
Returns for 10 years44.4635.50125%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.830.21
+1.66%
Viatris
DX12.420.04
+0.32%
Dynex Capital
GO17.82-0.29
-1.60%
Grocery Outlet Holding Corp
ADXN8.06-0.14
-1.71%
Addex Therapeutics Ltd
ATOS1.28-0.09
-6.57%
Atossa Therapeutics